Géraldine Honnet

818 total citations
5 papers, 142 citations indexed

About

Géraldine Honnet is a scholar working on Epidemiology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Géraldine Honnet has authored 5 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 2 papers in Molecular Biology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Géraldine Honnet's work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (2 papers) and vaccines and immunoinformatics approaches (1 paper). Géraldine Honnet is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (2 papers) and vaccines and immunoinformatics approaches (1 paper). Géraldine Honnet collaborates with scholars based in France, Germany and Romania. Géraldine Honnet's co-authors include Geneviève Inchauspé, Jean‐Marc Limacher, Jean‐Pierre Zarski, Myew–Ling Toh, Cyrille Féray, M. Maynard-Muet, Jean–Pierre Bronowicki, Christine Bain, Jean‐Yves Bonnefoy and Martine Baudin and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Géraldine Honnet

5 papers receiving 138 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Géraldine Honnet France 4 78 72 47 31 28 5 142
Laetitia Zona France 5 112 1.4× 105 1.5× 36 0.8× 19 0.6× 11 0.4× 7 195
Marine Turek France 5 134 1.7× 161 2.2× 25 0.5× 12 0.4× 21 0.8× 6 198
Sherif Gerges United States 4 118 1.5× 131 1.8× 35 0.7× 23 0.7× 27 1.0× 5 195
Hualong Xiong China 7 64 0.8× 42 0.6× 69 1.5× 13 0.4× 6 0.2× 11 169
Ofer Ben‐Moshe Israel 7 206 2.6× 184 2.6× 43 0.9× 18 0.6× 14 0.5× 9 265
Ralf Dürr Germany 7 178 2.3× 180 2.5× 53 1.1× 9 0.3× 43 1.5× 10 299
Hiromi Abe‐Chayama Japan 9 158 2.0× 132 1.8× 79 1.7× 17 0.5× 7 0.3× 22 245
Alexander McKenzie United States 4 194 2.5× 259 3.6× 20 0.4× 20 0.6× 14 0.5× 5 326
Francis Bodola United States 9 211 2.7× 249 3.5× 45 1.0× 20 0.6× 31 1.1× 14 341
Gururaj Kalkeri United States 8 73 0.9× 108 1.5× 25 0.5× 5 0.2× 6 0.2× 8 141

Countries citing papers authored by Géraldine Honnet

Since Specialization
Citations

This map shows the geographic impact of Géraldine Honnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Honnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Honnet more than expected).

Fields of papers citing papers by Géraldine Honnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Honnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Honnet. The network helps show where Géraldine Honnet may publish in the future.

Co-authorship network of co-authors of Géraldine Honnet

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Honnet. A scholar is included among the top collaborators of Géraldine Honnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Honnet. Géraldine Honnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Aronson, Sem J., P. Véron, Fanny Collaud, et al.. (2019). Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler–Najjar Syndrome. Human Gene Therapy. 30(10). 1297–1305. 43 indexed citations
2.
Sahel, José‐Alain, Anne Galy, Nitza Thomasson, et al.. (2015). Preliminary safety and tolerability results of intravitreal administration of GS010, a recombinant adeno-associated viral vector serotype 2 (rAAV2/2) containing human wildtype mitochondrial NADH dehydrogenase 4 (ND4) gene in patients with Leber Hereditary Optic Neuropathy (LHON) due to the G11778A ND4 mitochondrial DNA mutation. Investigative Ophthalmology & Visual Science. 56(7). 1088–1088. 1 indexed citations
3.
Mazur, Włodzimierz, Vicente Carréño, C Tănăsescu, et al.. (2014). Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection. Gastroenterology. 147(1). 119–131.e3. 24 indexed citations
4.
Habersetzer, François, Géraldine Honnet, Christine Bain, et al.. (2011). A Poxvirus Vaccine Is Safe, Induces T-Cell Responses, and Decreases Viral Load in Patients With Chronic Hepatitis C. Gastroenterology. 141(3). 890–899.e4. 66 indexed citations
5.
Zarski, Jean‐Pierre, Valériane Leroy, M. Maynard-Muet, et al.. (2009). 42 A NOVEL VECTORIZED HCV THERAPEUTIC VACCINE (TG4040): RESULTS OF A PHASE I STUDY IN NAIVE PATIENTS CHRONICALLY INFECTED BY HCV. Journal of Hepatology. 50. S18–S18. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026